RNAC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cartesian Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.54 USD 4.58% Market Closed

Market Cap: $199.9m

	Cartesian Therapeutics Inc NASDAQ:RNAC	US
N	Netflix Inc XBER:NFC	US
	Siyata Mobile Inc NASDAQ:CHAI	CA
	Matas A/S CSE:MATAS	DK
	Asiana IDT Inc KRX:267850	KR
D	D R Horton Inc LSE:0I6K	US

Profitability Summary

Cartesian Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-8.339%

Negative 3Y Average Operating Margin

-1.856%

Declining Operating Margin

-18% > -8.339%

Negative Net Margin

-8.699%

Negative 3Y Average Net Margin

-1.779%

Declining Net Margin

-18% > -8.699%

Negative Free Cash Flow Margin

-4.359%

Negative 3Y Average Free Cash Flow Margin

-1.182%

Declining Free Cash Flow Margin

-36% > -4.359%

Exceptional ROE

182%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-64%

Declining ROIC

-52% > -75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.